| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.0085 | 1 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.008 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |